NCT01604161

Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

A Multicentre, Open Label, Non-interventional Study to Evaluate on Long-term Safety and Efficacy of Norditropin® Formulation in Child Patients With GHD or Turner Short Stature Without Closure of Epiphyseal Discs.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,016 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This study is conducted in Japan. The aim of this study is to collect information about the efficacy and safety of Norditropin® (somatropin) in the long-term treatment of short stature with GHD (Growth Hormone Deficiency) where epiphysial discs are not closed and short stature with Turner Syndrome where epiphysial discs are not closed.

Conditions

• Growth Hormone Disorder
• Growth Hormone Deficiency in Children
• Genetic Disorder
• Turner Syndrome

Interventions

Type	Name	Description
DRUG	somatropin	Collection of safety and efficacy data in connection with use of somatropin (Norditropin®) in daily clinical practice.

Timeline

• Start date: 2005-05-01
• Primary completion: 2015-06-01
• Completion: 2015-06-01
• First posted: 2012-05-23
• Last updated: 2015-07-03

Locations

1 site across 1 country: Japan